BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29443806)

  • 1. HAND-HELD OPTICAL COHERENCE TOMOGRAPHY MONITORING OF CHEMORESISTANT RETINOBLASTOMA.
    Malik K; Welch RJ; Shields CL
    Retin Cases Brief Rep; 2020; 14(4):368-371. PubMed ID: 29443806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hand-held Optical Coherence Tomography Monitoring of Submillimeter Retinoblastoma Treated with Indocyanine Green-enhanced Transpupillary Therapy.
    Spencer MA; Welch RJ; Shields CL
    Middle East Afr J Ophthalmol; 2018; 25(2):108-110. PubMed ID: 30122857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful conservative treatment of massive choroidal relapse in 2 retinoblastoma patients monitored by ultrasound biomicroscopy and/or spectral domain optic coherence tomography.
    Stathopoulos C; Gaillard MC; Puccinelli F; Maeder P; Hadjistilianou D; Beck-Popovic M; Munier FL
    Ophthalmic Genet; 2018 Apr; 39(2):242-246. PubMed ID: 29099668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Swept-source optical coherence tomography features of regressed macular retinoblastoma.
    Damodaran S; Bajaj MS; Sharma P; Kumar A; Chawla R; Pujari A; Garg G; Temkar S
    Indian J Ophthalmol; 2019 Dec; 67(12):2013-2018. PubMed ID: 31755441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CLINICALLY INVISIBLE RETINOBLASTOMA RECURRENCE IN AN INFANT.
    Park K; Sioufi K; Shields CL
    Retin Cases Brief Rep; 2019 Spring; 13(2):108-110. PubMed ID: 28248744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous chemoreduction or intra-arterial chemotherapy for cavitary retinoblastoma: long-term results.
    Rojanaporn D; Kaliki S; Bianciotto CG; Iturralde JC; Say EA; Shields CL
    Arch Ophthalmol; 2012 May; 130(5):585-90. PubMed ID: 22652844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eye salvage in diffuse anterior retinoblastoma using systemic chemotherapy with periocular and intravitreal topotecan.
    Rao R; Honavar SG; Mulay K; Reddy VAP
    J AAPOS; 2018 Jun; 22(3):235-237.e2. PubMed ID: 29698780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hand-held spectral-domain optical coherence tomography of small macular retinoblastoma in infants before and after chemotherapy.
    Cao C; Markovitz M; Ferenczy S; Shields CL
    J Pediatr Ophthalmol Strabismus; 2014 Jul; 51(4):230-4. PubMed ID: 25922867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome.
    Russo I; Levy-Gabriel C; Dupont A; Lumbroso-Le Rouic L; Cassoux N; Desjardins L; Bertozzi AI; Coze C; Doz F; Savignoni A; Aerts I
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28721. PubMed ID: 33098751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H; Eagle RC; Shields CL; Shields JA
    Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trabeculectomy in eyes with unsuspected retinoblastoma.
    Chawla B; Hada M; Seth R; Sen S; Gupta V; Kashyap S; Narasimhaiah PC
    Ophthalmic Genet; 2016 Dec; 37(4):437-440. PubMed ID: 26966836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
    Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
    Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of primarily treated group D retinoblastoma.
    Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of iris neovascularization following chemoreduction of retinoblastoma.
    Patel J; Turaka K; Shields CL
    J Pediatr Ophthalmol Strabismus; 2010 Oct; 47 Online():e1-3. PubMed ID: 21162463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-arterial Chemotherapy for Adult Onset Retinoblastoma in a 32-Year-Old Man.
    Magan T; Khoo CT; Jabbour PM; Fuller DG; Shields CL
    J Pediatr Ophthalmol Strabismus; 2016 Jul; 53():e43-6. PubMed ID: 27486894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical Coherence Tomography of Small Retinoblastoma.
    Welch RJ; Rao R; Gordon PS; Say EAT; Shields CL
    Asia Pac J Ophthalmol (Phila); 2018; 7(5):301-306. PubMed ID: 29984562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.